Alaunos Therapeutics TCRT Q4 2023 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Compass COMP Q1 2026 Earnings EPS Beats Estimates by Wide Margin Despite Revenue Uncertainty FNV Q1 2026 Earnings EPS Surpasses Estimates by 137 as Royalty Portfolio Delivers BTSGU Q1 2026 Earnings Strong EPS Beat Surprises Market Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue VSCO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response GOVX Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress ESRT Q1 2026 Earnings Stable EPS Amid Market Uncertainty as Stock Slips DCBO Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains Penumbra PEN Q1 2026 Earnings EPS Misses Estimates by 245 as Revenue Details Remain Unclear Dragonfly Energy Q1 2026 Earnings EPS Misses Estimates as Losses Widen